检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Tralokinumab improves signs and symptoms of moderate-to-severe atopic dermatitis in patients aged 12 years and older with and without atopic comorbidities

Amy S. Paller,Weily Soong,Mark Boguniewicz,Bob Geng,Jacob P. Thyssen, Aldana Rosso, Louise Steffensen,Shannon Schneider,Andreas Wollenberg

BRITISH JOURNAL OF DERMATOLOGY（2024）

引用 0|浏览3
暂无评分
关键词
tralokinumab,moderate-to-severe,comorbidities,efficacy,safety
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要